Children's hospital of Fudan university
Shanghai, Shanghai Municipality, 200000, China
NCT Number: NCT03708094
Kidney transplantation is the worldwide recognized best renal replacement treatment for children with end-stage renal disease. Successful kidney transplantation can not only alleviate uremia symptoms, improve survival and quality of life, but also achieve optimal growth and cognitive development in children. Clarifying the cause of end-stage renal disease before transplantation is of vital importance to the comprehensive assessment and follow-up of the extra renal organs, reducing the risk of recurrence of the primary disease, the choice of the timing and the mode of transplantation, the scheme of immunosuppressive agents, as well as providing accurate genetic counseling for families. Timely molecular diagnosis and correct data analysis play a positive role in promoting the etiological diagnosis of uremic children before renal transplantation. We hypothesized that identifying the molecular diagnosis can improve prognosis of kidney transplantation. 300 cases of end-stage renal disease children were included and whole exome sequencing are performed to identify the molecular diagnosis. The cohort was divided into 2 groups according to whether the molecular diagnosis was clear. Clinical information before and after renal transplantation of each group are collected, and the decision tree analysis model and logistic regression model are used to study the effect of clear molecular diagnosis on the 3 year survival rate of renal transplantation.
Looking for future studies?
Notify MeUp to 18 year
All sexes
Observational
Shanghai, Shanghai Municipality, 200000, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
whole exome sequencing and data analysis to elucidating molecular diagnosis
Time frame: 3 years after renal transplantation
The number of survival renal transplant graft in the 3 year observation period accounted for the percentage of the total cases studied.
Time frame: 3 years after renal transplantation
The number of acute rejection after transplantation during the 3 year observation period accounted for the percentage of the total cases studied.
Time frame: 3 years after renal transplantation
The number of patient with primary disease recurrence during the 3 year observation period accounted for the percentage of the total cases studied.
Children's Hospital of Fudan University
Other
A Study for Predicting the Prognosis of Renal Transplantation by the Clear Pathogenic Gene of End-stage Renal Disease in Children
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03418181
Dialysis, Female Urogenital Diseases
Stevenage, United Kingdom
View Trial DetailsNCT07704008
Anxiety Disorders, Female Urogenital Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT01595984
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Amiens, France
View Trial DetailsNCT00213590
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Rouen, France
View Trial Details